Literature DB >> 12060506

Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor.

O Köse1, H Bülent Taştan, A Riza Gür, Z Kurumlu.   

Abstract

BACKGROUND: Tinea (pityriasis) versicolor is a superficial infection of the stratum corneum by the lipophilic fungus known as Malassezia furfur.
OBJECTIVE: To evaluate the efficacy and safety of a 400 mg single dose or 7-day 200 mg daily dose of itraconazole capsules in the treatment of mycologically confirmed pityriasis versicolor.
METHODS: A total of 50 patients were entered into a randomized, open, clinical trial comparing a 400 mg single dose (n = 24 for group 1) with a 7-day 200 mg daily dose (n = 26 for group 2) of itraconazole. Clinical signs and symptoms and mycologic evaluation (potassium hydroxide preparation and Wood's lamp) were performed before treatment, and at weeks 3 and 6 after treatment.
RESULTS: Both regimens of itraconazole were effective. Our results showed that there were no significant differences in efficacy and safety between the two treatment regimens (chi-square tests, p > 0.05).
CONCLUSIONS: On the basis of these findings, a single dose of itraconazole 400 mg/day was as effective as the 7-day 200 mg daily dose in the treatment of pityriasis versicolor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060506     DOI: 10.1080/095466302317584430

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  4 in total

Review 1.  Microreview of Pityriasis versicolor and Malassezia species.

Authors:  N Morishita; Y Sei
Journal:  Mycopathologia       Date:  2006-12       Impact factor: 2.574

Review 2.  Skin conditions of baseball, cricket, and softball players.

Authors:  Joshua A Farhadian; Brook E Tlougan; Brian B Adams; Jonathan S Leventhal; Miguel R Sanchez
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

3.  Pityriasis Versicolor Resistant to Antifungal Drugs in a Patient in Lomé (Togo).

Authors:  Julienne Teclessou; Koussake Kombate; Bayaki Saka; Séfako Abla Akakpo; Palokinam Pitche
Journal:  Case Rep Dermatol Med       Date:  2022-08-22

Review 4.  Antifungal Treatment for Pityriasis Versicolor.

Authors:  Aditya K Gupta; Kelly A Foley
Journal:  J Fungi (Basel)       Date:  2015-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.